SIMPONI ARIA®Simponi Aria (golimumab)
FDA INDICATION: Adult patients with moderately to severely active rheumatoid arthritis in combination with methotrexate, active psoriatic arthritis, active ankylosing spondylitis. Prescribing Information
DISTRIBUTOR: Janssen Biotech
ROUTE OF ADMINISTRATION: Intravenous
DOSAGE AND ADMINISTRATION: 2 mg/kg intravenous infusion over 30 minutes at weeks 0 and 4, then every 8 weeks.
HOW SUPPLIED: 50 mg/4 mL (12.5 mg/mL) solution in a single-dose vial.
STORAGE REQUIREMENTS: Refrigerate at 36°F to 46°F (2°C to 8°C) and protect from light. Do not freeze. Do not shake. If needed, vials may be stored at room temperature up to 77°F (25°C) for a maximum single period of 30 days in the original carton to protect from light. Once stored at room temperature, do not return the product to the refrigerator.